Facebook CatchUp is new group calling app, 5 things to know
Social media giant Facebook had announced a newgroup-calling app called the CatchUp. The CatchUp would allow users to set up group calls with up to 8 people. Social media giant Facebook had announced a new group-calling app called the CatchUp. The CatchUp would allow users to set up group calls with up to 8 people. However, there is a catch, it is not a video calling app but an audio-only app. The app is being developed by Facebook NPE. For video-calling services, Facebook had earlier released a Messenger Rooms app that can allow up to 50 people to connect in a single call. However, this is Facebook's first audio-only application. Talking about the CatchUp app Facebook had said in a blog post, "Keeping in touch with friends and family is important, especially during this time of physical distancing. Messaging and video calls are great ways to send a quick update or connect with someone face-to-face, but speaking to someone over the phone offers a unique balance of both conve...
Coronavirus (Covid-19) vaccine latest update: As countries scramble to stem the spread of Covid-19, the US government’s top infectious disease expert, Anthony Fauci, has provided some hope of a vaccine being ready as early as November even as epidemiology experts have warned that the novel coronavirus might not go away with the development of an injection.
The experts have said the novel coronavirus would likely remain for years to come, and may eventually, become endemic like HIV, measles and chickenpox, a report in The Washington Post said.
According to the World Health Organization (WHO), more than 100 vaccines are being developed across the world,
with 10 candidates already in human trials. Till date, China’s CanSino adenovirus vaccine, Oxford University’s adenovirus vaccine, Moderna’s mRNA vaccine and Novavax have emerged as the top most promising vaccine candidates for Covid-19.
Coronavirus (Covid-19) vaccine latest updates:
💉 Shares of Moderna Inc, which last week reported successful results from its experimental vaccine, tumbled this week after a report highlighted side effects in a volunteer taking part in a trial
A volunteer told STAT News that he started getting chills within hours of getting home from his second dose and had nausea and aching muscles. He said he had received the highest dose from the trials — one 10 times stronger than others. However, he maintained that as sick as he was, it was never “life-threatening”, according to report in The New York Post.
READ | What govt said on vaccines being developed in India
Moreover, Moderna Inc, which said its candidate produced protective antibodies in a small group of healthy volunteers, has extended a deal with pharmaceutical ingredient supplier CordenPharma to secure large volumes of the lipids used to produce its vaccine, Reuters reported.
Moderna plans to supply millions of doses per month in 2020 and tens of millions a month in 2021 if the vaccine proves successful.